Court Square Capital Recapitalizes Medical Knowledge Group
January 8, 2020
Investment funds managed by Court Square Capital Partners completed a recapitalization of Medical Knowledge Group, a New York–based analytics-driven commercialization and multi-channel marketing solutions provider to biopharmaceutical companies. The transaction provides Medical Knowledge Group’s management with additional resources to pursue growth initiatives; WindRose Health Investors, the prior majority sponsor, facilitated the sale as part of an investor exit.
- Buyers
- Court Square Capital Partners (investment funds managed by Court Square)
- Targets
- Medical Knowledge Group, LLC
- Sellers
- WindRose Health Investors, LLC
- Industry
- Healthcare Services
- Location
- New York, United States
- Transaction Type
- Recapitalization
Explore More
Related Acquisitions
-
Novo Holdings Acquires Medical Knowledge Group
January 3, 2022
Healthcare Services
Novo Holdings A/S has agreed to acquire Medical Knowledge Group (MKG) from Court Square Capital and Aisling Capital. MKG is an analytics-driven, technology-enabled drug commercialisation and medical communications platform headquartered in New York with more than 500 employees; Novo said the acquisition will support MKG's continued growth in biopharmaceutical commercialisation services.
-
Medical Knowledge Group Acquires Magnolia Innovation
October 12, 2020
Healthcare Services
Medical Knowledge Group (MKG), a portfolio company of Court Square Capital Management, has acquired Magnolia Innovation, a boutique market research and strategy consulting firm serving the biopharmaceutical industry. The acquisition expands MKG's research and commercialization capabilities by combining Magnolia's life-sciences market-insight expertise with MKG's analytics-driven solutions; Hyde Park Capital served as exclusive advisor to Magnolia.
-
Court Square Capital Partners and WindRose Health Investors Recapitalize Soleo Health
February 3, 2025
Healthcare Services
Court Square Capital Partners and WindRose Health Investors announced a jointly controlled recapitalization of Soleo Health, a Frisco, Texas-based provider of specialty pharmacy and infusion services. The investment will provide capital to scale Soleo's national footprint (26 pharmacies, 30+ infusion suites) and support growth across all 50 states while partnering with the company's founders and management team.
-
Court Square Capital Partners Recapitalizes J. Knipper and Company and KnippeRx
October 2, 2019
Healthcare Services
Court Square Capital Partners recapitalized J. Knipper and Company, Inc. and its affiliate KnippeRx, with the Knipper family selling majority shares and remaining minority owners. The transaction installs Michael Laferrera as CEO and elevates Frank McNicholas to COO (in addition to CFO) and is intended to accelerate growth and strengthen the company's position across pharmaceutical sample management, specialty pharmacy and 3PL services.
-
WindRose Health Investors Recapitalizes Lykan Bioscience Holdings
June 4, 2019
Biotechnology
WindRose Health Investors completed an equity recapitalization of Lykan Bioscience Holdings, LLC, a Hopkinton, Massachusetts-based contract manufacturing services organization focused on cell and gene therapy production and logistics. The investment provides capital to support growth and the build-out of a 60,000+ square foot cGMP facility to expand manufacturing capacity; terms were not disclosed.
-
WindRose Health Investors Recapitalizes Healthmap Solutions
May 21, 2019
Healthcare Services
WindRose Health Investors completed an $85 million equity recapitalization of Healthmap Solutions to provide growth capital and support the company's expansion into new markets. Healthmap, a specialty population health management firm focused on kidney disease, will continue to be led by CEO Joe Vattamattam and COO & Founder Andrew Wall.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.